| Name | Title | Contact Details |
|---|
Kryo, Inc. is the world`s leading innovator of temperature-regulated and climate-control sleep solutions engineered to optimize health and wellness through enhanced quality sleep and patented technology. Kryo ranks no. 615 on the 2020 Inc. 5000 list.
Themis Vision Systems is a Stennis Space Center, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wuhan General Group, Inc. through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercialises a range of CBD-based products under the Dr. AnnaRx™ and Medspresso™ brands.
C C Young is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Dallas, TX. To find more information about C C Young, please visit www.ccyoung.org
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.